| Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies SV Bhujbal, B Mitra, U Jain, Y Gong, A Agrawal, S Karki, LS Taylor, ... Acta Pharmaceutica Sinica B 11 (8), 2505-2536, 2021 | 373 | 2021 |
| Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption Y Shi, P Gao, Y Gong, H Ping Molecular pharmaceutics 7 (5), 1458-1465, 2010 | 142 | 2010 |
| Solid forms of N-[2, 4-BIS (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawiec, ... US Patent App. 11/647,505, 2011 | 127 | 2011 |
| Solid forms of N-[2, 4-bis (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawiec, ... US Patent 8,410,274, 2013 | 108 | 2013 |
| 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment AG Tabriz, U Nandi, AP Hurt, HW Hui, S Karki, Y Gong, S Kumar, ... International Journal of Pharmaceutics 593, 120147, 2021 | 91 | 2021 |
| Solid forms of N-[2, 4-bis (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawlec, ... US Patent 8,754,224, 2014 | 79 | 2014 |
| Solid forms of N-[2, 4-bis (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawiec, ... US Patent 9,139,530, 2015 | 70 | 2015 |
| Microfluidic approach to cocrystal screening of pharmaceutical parent compounds S Goyal, MR Thorson, GGZ Zhang, Y Gong, PJA Kenis Crystal growth & design 12 (12), 6023-6034, 2012 | 61 | 2012 |
| Salts and crystalline forms of an apoptosis-inducing agent ND Catron, S Chen, Y Gong, GG Zhang | 58 | 2017 |
| Salts and crystalline forms of an apoptosis-inducing agent ND Catron, S Chen, Y Gong, GG Zhang | 58 | 2015 |
| Salts and crystalline forms of an apoptosis-inducing agent N Catron, S Chen, Y Gong, GG Zhang US Patent 8,722,657, 2014 | 58 | 2014 |
| Stable-form screening: Overcoming trace impurities that inhibit solution-mediated phase transformation to the stable polymorph of sulfamerazine Y Gong, BM Collman, SM Mehrens, E Lu, JM Miller, A Blackburn, ... Journal of pharmaceutical sciences 97 (6), 2130-2144, 2008 | 56 | 2008 |
| Low-concentration polymers inhibit and accelerate crystal growth in organic glasses in correlation with segmental mobility CT Powell, T Cai, M Hasebe, EM Gunn, P Gao, G Zhang, Y Gong, L Yu The Journal of Physical Chemistry B 117 (35), 10334-10341, 2013 | 53 | 2013 |
| Microfluidic approach to polymorph screening through antisolvent crystallization MR Thorson, S Goyal, Y Gong, GGZ Zhang, PJA Kenis CrystEngComm 14 (7), 2404-2412, 2012 | 53 | 2012 |
| A microfluidic platform for pharmaceutical salt screening MR Thorson, S Goyal, BR Schudel, CF Zukoski, GGZ Zhang, Y Gong, ... Lab on a Chip 11 (22), 3829-3837, 2011 | 53 | 2011 |
| Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers AG Tabriz, N Scoutaris, Y Gong, HW Hui, S Kumar, D Douroumis International Journal of Pharmaceutics 604, 120755, 2021 | 50 | 2021 |
| Solid forms of N-[2, 4-bis (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawiec, ... US Patent 9,670,163, 2017 | 46 | 2017 |
| Crystallization optimization of pharmaceutical solid forms with X-ray compatible microfluidic platforms EM Horstman, S Goyal, A Pawate, G Lee, GGZ Zhang, Y Gong, PJA Kenis Crystal Growth & Design 15 (3), 1201-1209, 2015 | 36 | 2015 |
| Principles of solubility Y GONG, DJW GRANT, HG BRITTAIN Solvent systems and their selection in pharmaceutics and biopharmaceutics, 1-27, 2007 | 36 | 2007 |
| Solid forms of N [2, 4-bis (1, 1-dimethylethyl)-5-hydroxyphenyl]-1, 4-dihydro-4-oxoquinoline-3-carboxamide P Hurter, W Rowe, CR Young, A Costache, PR Connelly, M Krawiec, ... US Patent 9,931,334, 2018 | 35 | 2018 |
